Friday, 9 February 2018

The scientific-program of Molecular Medicine 2018 Conference is a rich mix of Interactive Sessions, keynote lectures from industry experts, panel discussions, poster competitions and Young Researcher Forum. The conference program will feature well-known and thought-provoking speakers to interactive discussion sessions.

Current Research on Diagnostics:

Molecular Diagnostics were mostly for infections and viruses but are now ascending in the areas of genetic disorders, practice of a plan in screening of cancer. The molecular diagnostics technology will play an important role in practice of medicine, public health, pharmaceutical industry, and biological disorders. The tests, despite some restrictions is a promising area for future expansion of in diagnostic market analysis. It is always combined with therapeutics and forms an important component of integrated healthcare, and diagnostic technologies are also involved in development of personalized health care medicine based on genetics and genomics health care issues, there has been an interested in developing rapid growth of diagnostic methods for point of care and biowarfare agents. In that, nanobiotechnology are expected to make a significant contribution to the growth of molecular diagnostics. In USA, the development of molecular diagnostics has pre-dominant role, which contains more number of diagnostics companies and pharma industries which related to the diagnostic health cares.

Friday, 2 February 2018

Molecular Medicine 2018 Conference: 

Present advantage of calcium phosphate is that our body does not treat it as foreign material, leading to minimum toxicity and immune rejection compared to other nanoparticles which are non-biodegradable. 

Effect of Time to Diagnostic Testing for Breast Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: Compared to immediate diagnostic testing, testing at 3 months resulted in reduced screening benefit

Session Tracks on: Diagnostics:

The development of calcium phosphate nanoparticles along with imageable properties for drug delivery is a major innovation. It is the quest to develop biodegradable contrast agents for imaging (diagnostic) purposes. 

Calcium phosphate as might be expected in human bones and is non-toxic and fully bio degradable. It can be guided precisely to cancer tumor’s, which will enable their treatment under image guidance, using some radio waves to heat up and destroy the cancer cells. presently, the most common treatment for cancer involves radiation and use of gamma rays to kill cancer cells. This inflicts collateral damage: healthy cells also get destroyed. Radiation treatment with cyber knife is much more precise, but very expensive.

Saturday, 6 January 2018

Present Research Molecular Medicine 2018 Conference Focuses on:

Presently Molecular Medicine 2018 mainly concentrates on the Utilization of targeted near-infrared molecular imaging to improve pulmonary metastasectomy of osteosarcomas. Researchers proclaim that targeted fluorescence effectively recognised pulmonary metastases in a patient with osteosarcoma, making it easier for surgeons to locate the tumours for resection. More than 90% of primary lung cancers accumulate OTL38 and generate tumour fluorescence during minimally invasive pulmonary resection, suggesting that this technique may have application beyond pulmonary osteosarcoma.

Future Research: Future research will explore if this approach could be applicable to other pulmonary malignancies that express the FRĪ±.

Keynote Speech:

Hildegund C.J. Ertl

Director, World Health Organization (WHO), Professor
The Wistar Institute
Philadelphia, USA


“Improving the outcome of T-cell immunotherapy of cancers by pre-conditioning T cell metabolism towards fatty acid catabolism”

Wednesday, 20 December 2017

About Conference

International Conference on Molecular Medicine to be held during August 19-20, 2018 at Dubai, UAE, focusing on “Exploring the modern Innovations in the field of Molecular Medicine and Diagnostics

Molecular Medicine 2018 will provide exposure to the on-going researches in Molecular Medicine and related science. It will also provide insight to the novel inventions and techniques. It is very beneficial for the student Molecular Genetics and fellowship owners because it provides knowledge in the field. It also gives opportunities to the companies to showcase their products and have face to face meetings with scientists increasing their business opportunities. Molecular Medicine 2018 also gives companies to know about their market competitors. Genetic disorder is a major risk factor for Genetic diseases, Molecular medicine and Diagnostic Events so is therefore one of the most important preventable causes of premature morbidity and mortality in developed and developing countries. It is often symptomless, so screening is vital before damage is done. Many surveys conducted by Diagnostics World, provides insight into the practices and opinions of those in drug research and development.
Present Research:
Currently the research on molecular medicine was focused on the advances in Molecular Perspectives of Tumor-Initiating Cells on Cancer Therapy, the origin of molecular medicine are also focuses on the Hemoglobin research, Molecular Diagnostic also currently challenges on the Cardiovascular and the field of cardiovascular genetics has tremendously benefited from the recent application of massive parallel sequencing technology also referred to as next generation sequencing. 3rd International conference on Molecular Medicine and Diagnostics topics are mainly focuses on the above trended material which is going to be held in Dubai, UAE during April 19-20, 2018.
Target Audience:
Molecular Medicine 2018 is expecting the participants from all over the globe in various fields. This combination of audience will give an ideal blend to justify our theme “Exploring the Modern Innovations in the Field of Molecular Medicine and Diagnostics” Molecular Medicine 2018 expecting attendees from,
• Molecular Professors
• Doctors
• Professors, Researchers, Students and Technical Staff from the field of Molecular
• Clinical Researchers and Scientists
• Directors/Co-Directors of Research based companies across Europe and US who are investing in Molecular Field
Who to attend?
• Health-care
• Clinical EP
• Internal Medicine
• Preventive Healthcare Medicine
• Molecular Pathology
• Molecular Imaging
• Emergency Medicine
• Nuclear Medicine
• Molecular Biology
• Molecular Biophysics
• Molecular Oncology
• Cell Biology
• Vascular Medicine
• Immunology
• Virology

Join us in Dubai, UAE for the leading Annual Molecular event

Alex Smith
Program Director